 NEW YORK, Feb. 26, 2021 PRNewswire -- Hoth Therapeutics, Inc. NASDAQ: HOTH, a biopharmaceutical company, today announced it has expanded its licensing agreement from North Carolina State University NC State to include the worldwide development and commercialization of treatments... 